Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial - Concepedia

Concepedia

Publication | Closed Access

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

152

Citations

27

References

2014

Year

Michaëla Diamant, Luc Van Gaal, Bruno Guerci, Stephen Stranks, Jenny Han, Jaret Malloy, Marilyn K. Boardman, Michael Trautmann

The Lancet Diabetes & Endocrinology

Diabetes ManagementInsulin ManagementDiabetesPharmacologyClinical TrialsType 2Pharmacotherapy3-Year ResultsDiabetes MellitusOpen-label Randomised TrialInsulin DeliveryMedicine

References

	Year	Citations

Page 1

Page 1